JP2025512805A - Ｉｋｚｆ２分解剤及びその使用 - Google Patents

Ｉｋｚｆ２分解剤及びその使用 Download PDF

Info

Publication number
JP2025512805A
JP2025512805A JP2024556604A JP2024556604A JP2025512805A JP 2025512805 A JP2025512805 A JP 2025512805A JP 2024556604 A JP2024556604 A JP 2024556604A JP 2024556604 A JP2024556604 A JP 2024556604A JP 2025512805 A JP2025512805 A JP 2025512805A
Authority
JP
Japan
Prior art keywords
carbocyclyl
alkyl
heterocyclyl
compound
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024556604A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025512805A5 (enExample
Inventor
ジーシャン チェン
ロハン レイ
シューキン チャン
ロンチュアン バイ
ポール キルヒホフ
シャオメン ワン
Original Assignee
リージェンツ オブ ザ ユニバーシティー オブ ミシガン
オンコピア セラピューティクス インコーポレイテッド ディー／ビー／エー エスケー ライフ サイエンス ラボズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リージェンツ オブ ザ ユニバーシティー オブ ミシガン, オンコピア セラピューティクス インコーポレイテッド ディー／ビー／エー エスケー ライフ サイエンス ラボズ filed Critical リージェンツ オブ ザ ユニバーシティー オブ ミシガン
Publication of JP2025512805A publication Critical patent/JP2025512805A/ja
Publication of JP2025512805A5 publication Critical patent/JP2025512805A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024556604A 2022-03-25 2023-03-24 Ｉｋｚｆ２分解剤及びその使用 Pending JP2025512805A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263323792P 2022-03-25 2022-03-25
US63/323,792 2022-03-25
US202363446105P 2023-02-16 2023-02-16
US63/446,105 2023-02-16
PCT/US2023/016177 WO2023183540A1 (en) 2022-03-25 2023-03-24 Ikzf2 degraders and uses thereof

Publications (2)

Publication Number Publication Date
JP2025512805A true JP2025512805A (ja) 2025-04-22
JP2025512805A5 JP2025512805A5 (enExample) 2026-03-31

Family

ID=86185384

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024556604A Pending JP2025512805A (ja) 2022-03-25 2023-03-24 Ｉｋｚｆ２分解剤及びその使用

Country Status (7)

Country Link
US (1) US20250215012A1 (enExample)
EP (1) EP4499649A1 (enExample)
JP (1) JP2025512805A (enExample)
KR (1) KR20250026153A (enExample)
CN (1) CN119731179A (enExample)
TW (1) TW202341988A (enExample)
WO (1) WO2023183540A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2024008868A (es) 2022-01-18 2024-09-23 Maze Therapeutics Inc Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso.
EP4471033A4 (en) * 2022-01-29 2026-03-25 Gan & Lee Pharmaceuticals Co Ltd CEREBLON UBIQUITIN LIGASE E3 INHIBITOR
CN117065022A (zh) * 2022-05-17 2023-11-17 海创药业股份有限公司 一种治疗三阴乳腺癌的药物
WO2025261456A1 (zh) * 2024-06-19 2025-12-26 甘李药业股份有限公司 一种雌激素受体蛋白降解靶向嵌合体化合物及其应用
WO2026035999A1 (en) 2024-08-09 2026-02-12 Triana Biomedicines, Inc. Anaplastic lymphoma kinase (alk) degraders and uses thereof
WO2026139085A1 (zh) * 2024-12-27 2026-07-02 甘李药业股份有限公司 酪蛋白激酶1α(CK1α)分子胶降解剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI793151B (zh) * 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
CA3123519A1 (en) * 2019-02-15 2020-08-20 Novartis Ag Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
WO2021087093A1 (en) * 2019-10-30 2021-05-06 Dana-Farber Cancer Institute, Inc. Small molecule degraders of helios and methods of use
EP4168007A1 (en) * 2020-06-23 2023-04-26 Novartis AG Dosing regimen comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives
EP4188549A1 (en) * 2020-08-03 2023-06-07 Novartis AG Heteroaryl substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Also Published As

Publication number Publication date
KR20250026153A (ko) 2025-02-25
US20250215012A1 (en) 2025-07-03
EP4499649A1 (en) 2025-02-05
TW202341988A (zh) 2023-11-01
WO2023183540A1 (en) 2023-09-28
CN119731179A (zh) 2025-03-28

Similar Documents

Publication Publication Date Title
JP7320595B2 (ja) インターロイキン－１活性の阻害剤としてのスルホンイミドアミド化合物
EP4499649A1 (en) Ikzf2 degraders and uses thereof
KR101862493B1 (ko) Fgfr4 억제제로서의 고리-융합된 비시클릭 피리딜 유도체
KR20250135228A (ko) Vav1의 표적 분해
AU2009231714B2 (en) Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
WO2020103896A1 (en) Pyrrolo[2,3-b]pyridines as hpk1 inhibitor and uses thereof
KR20220061958A (ko) Cd38의 억제제로서의 헤테로바이사이클릭 아미드
JP2020523418A (ja) Ｉｌ−１７調節剤としてのスピロ環インドリン
BR112020003373B1 (pt) Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona, usos dos mesmos e composição farmacêutica
KR102731924B1 (ko) 파르네소이드 x 수용체 조정제로서의 스피로시클릭 화합물
US20250195484A1 (en) Cereblon ligands and uses thereof
MX2013005603A (es) Derivados de pirrolopiridina sustituidos con ciclobutilo como inhibidores de janus cinasas (jak).
WO2013173720A1 (en) Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
JP2025510834A (ja) Ｉｋｚｆ２分解剤としての二環式ヘテロアリール含有化合物
KR20160135363A (ko) 비시클릭-융합된 헤테로아릴 또는 아릴 화합물 및 ｉｒａｋ４ 억제제로서의 그의 용도
AU2010306954A1 (en) CGRP receptor antagonists
JP2014518214A (ja) Ｔｒｐｖ４拮抗薬
AU2011279845B2 (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists
EP4457230A1 (en) Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
WO2024192064A1 (en) Compounds and compositions as smarca2/4 degraders and uses thereof
JP2025526290A (ja) エストロゲン受容体分解剤としてのテトラヒドロナフタレン誘導体
TW202412784A (zh) 氮-喹唑啉化合物及使用方法
UA129879C2 (uk) Макроциклічні інгібітори rip2-кінази
TW202417458A (zh) 調節her2的化合物及方法
KR20230035437A (ko) 7-치환된 1-아릴-나프티리딘-3-카르복실산 아미드 및 그의 용도

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260323

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260708